UBS Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06B | Buy |
|
|||||
|
2025
Q1 | $3.17B | Buy |
|
|||||
|
2024
Q4 | $2.63B | Sell |
|
|||||
|
2024
Q3 | $3.19B | Buy |
|
|||||
|
2024
Q2 | $2.68B | Buy |
|
|||||
|
2024
Q1 | $2.09B | Buy |
|
|||||
|
2023
Q4 | $1.48B | Buy |
|
|||||
|
2023
Q3 | $1.19B | Sell |
|
|||||
|
2023
Q2 | $1.14B | Buy |
|
|||||
|
2023
Q1 | $800M | Buy |
|
|||||
|
2022
Q4 | $698M | Buy |
|
|||||
|
2022
Q3 | $340M | Sell |
|
|||||
|
2022
Q2 | $385M | Sell |
|
|||||
|
2022
Q1 | $350M | Sell |
|
|||||
|
2021
Q4 | $398M | Buy |
|
|||||
|
2021
Q3 | $329M | Buy |
|
|||||
|
2021
Q2 | $307M | Buy |
|
|||||
|
2021
Q1 | $211M | Sell |
|
|||||
|
2020
Q4 | $236M | Buy |
|
|||||
|
2020
Q3 | $156M | Sell |
|
|||||
|
2020
Q2 | $180M | Sell |
|
|||||
|
2020
Q1 | $164M | Sell |
|
|||||
|
2019
Q4 | $210M | Buy |
|
|||||
|
2019
Q3 | $145M | Buy |
|
|||||
|
2019
Q2 | $134M | Sell |
|
|||||
|
2019
Q1 | $171M | Buy |
|
|||||
|
2018
Q4 | $135M | Sell |
|
|||||
|
2018
Q3 | $140M | Sell |
|
|||||
|
2018
Q2 | $112M | Sell |
|
|||||
|
2018
Q1 | $115M | Sell |
|
|||||
|
2017
Q4 | $128M | Buy |
|
|||||
|
2017
Q3 | $103M | Sell |
|
|||||
|
2017
Q2 | $119M | Buy |
|
|||||
|
2017
Q1 | $107M | Sell |
|
|||||
|
2016
Q4 | $169M | Buy |
|
|||||
|
2016
Q3 | $156M | Sell |
|
|||||
|
2016
Q2 | $186M | Sell |
|
|||||
|
2016
Q1 | $187M | Buy |
|
|||||
|
2015
Q4 | $103M | Buy |
|
|||||
|
2015
Q3 | $69.4M | Buy |
|
|||||
|
2015
Q2 | $54.2M | Sell |
|
|||||
|
2015
Q1 | $66.6M | Sell |
|
|||||
|
2014
Q4 | $65.9M | Buy |
|